Procurement Summary
Country: Czech Republic
Summary: Medicinal Preparations Containing Immunoglobulins for Extravascular Application
Deadline: 04 May 2026
Posting Date: 01 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138830036
Document Ref. No.: 226237-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: CZK 28250000
CPV Classification
33651520 - Immunoglobulins
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The subject of the public contract is the ongoing supply of medicinal products with content immunoglobulins for extravascular application for a period of 4 years according to the current needs of the client. Part 4 The subject of the public contract is the ongoing supply of medicinal products with content immunoglobulins for extravascular application for a period of 4 years according to the current needs of the client. Name of active substance, strength, dosage form and packaging: HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 165MG/ML INJ SOL 1X6ML NORMAL HUMAN IMMUNOGLOBULIN PRO SUBCUTANEOUS ADMINISTRATION 165MG/ML INJ SOL 1X12ML HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 165MG/ML INJ SOL 1X20ML Part 5 The subject of the public contract is the ongoing supply of medicinal products with content immunoglobulins for extravascular application for 4 years according to the client's current needs. Name of active substance, strength, dosage form and packaging: HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 200MG/ML INJ SOL 1X5ML HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 200MG/ML INJ SOL 1X10ML NORMAL HUMAN IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 200MG/ML INJ SOL 1X20ML HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 200MG/ML INJ SOL 1X50ML Part 3 The subject of the public contract is the ongoing supply of medicinal products with content immunoglobulins for extravascular application for a period of 4 years according to the client's current needs. Name of active substance, strength, dosage form and packaging: HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS ADMINISTRATION 100MG/ML INF SOL 1X25ML+1X1.25ML HUMAN NORMAL IMMUNOGLOBULIN FOR SUBCUTANEOUS...
Document Type: Contract Notice Reference Number: 37/2026 Contract Type: supplies Estimated Value: 28250000 - CZK Authority Type: body-pl-cga Doc Title: Medicinal preparations containing immunoglobulins for extravascular application Dispatch Date: 2026-03-31 Publish Date: 2026-04-01 Submission Date: 2026-05-04
Documents
Tender Notice